Once Global to Launch AI Drug Information Platform 'ConnectDI+'

## Once Global Launches AI Pharmaceutical Information Platform 'ConnectDI+'… Minimizing 'AI Hallucination' Based on MFDS Data Once Global is set to unveil 'ConnectDI+', a next-generation pharmaceutical data platform that combines artificial...

Nov 3, 2025 - 00:00
 0  967
Once Global to Launch AI Drug Information Platform 'ConnectDI+'
## Once Global Launches AI Pharmaceutical Information Platform 'ConnectDI+'… Minimizing 'AI Hallucination' Based on MFDS Data Once Global is set to unveil 'ConnectDI+', a next-generation pharmaceutical data platform that combines artificial intelligence (AI) with an innovative data structure. This platform aims to evolve beyond simple search, with AI understanding pharmaceutical data and explaining necessary information to users as an intelligent service. ConnectDI+'s core feature, the AI search service 'Dr.DI', accurately compiles and provides information such as ingredients, efficacy, indications, and precautions, based solely on official approval data from the Ministry of Food and Drug Safety (MFDS), when users input natural language queries like "Tell me the precautions when combining ibuprofen and acetaminophen." This minimizes the 'AI hallucination' phenomenon, often cited as a chronic problem in general generative AI, thereby ensuring highly reliable information that can be immediately utilized in clinical settings and pharmacy operations. In the future, Dr.DI plans to expand into a service that integrates with the Drug Utilization Review (DUR) service, allowing AI to analyze and present more in-depth medication information, including for complex drugs. In addition, ConnectDI+ will newly incorporate the 'APAC data structure' developed by Once Global. This structure analyzes drugs from four multidimensional perspectives: Anatomical, Pharmaceutical, Action Mechanism, and Chemical Mechanism. This helps to systematically and deeply understand aspects such as comparing ingredients in complex drugs or searching for key ingredients by efficacy. Park Kyeong-ha, CEO of Once Global, stated, "ConnectDI+ will be a significant turning point towards an AI-driven pharmaceutical information platform that goes beyond simply 'querying' pharmaceutical data to one where AI 'understands and explains' it. It will firmly establish itself as a reliable pharmaceutical information search service for both domestic and international medical professionals and general users alike."

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0